Get an early preview of the new iBridge Network

Access new technology search features and an extended innovation database with new transformative technologies
fed into the platform by our member Academic Institutions, Research Labs, SMEs, Startups


Ubiquitination assay

Sanford-Burnham Medical Research Institute
posted on 07/07/2009

                                            Signal Transduction


A method for assaying ubiquitination and identifying modulators of ubiquitination to regulate aberrant signal transduction.



·        Multi-well array analysis for high throughput screening

·        Can be used independent of the E3 ubiquitination enzyme



Ubiquitin is a highly conserved protein expressed in all eukaryotic cells. The levels of many intracellular proteins are regulated by a ubiquitin-dependent proteolytic process. This process involves the covalent ligation of ubiquitin to a target protein, resulting in a poly-ubiquitinated target protein that is rapidly detected and degraded. The ubiquitination of these proteins is mediated by a cascade of enzymatic activities, with E3 being the final enzyme used in the cascade. In this process, chains of ubiquitin are formed on the target protein, each covalently ligated to the next through the activity of E3. Modulators of ubiquitination can be used to upregulate or downregulate specific molecules involved in cellular signal transduction. Disease processes can be treated by such up- or down regulation of signal transducers. Due to the importance of ubiquitination in cellular regulation, the current invention provides a means for assaying ubiquitination and identifying modulators of ubiquitination.


Lead Inventor

John C. Reed, M.D., Ph.D.

Reed lab homepage


Selected References

List of references via Pubmed


Patent Information

Full title:  E3- independent ubiquitinylation assay

U.S. Patent/Application #: 61/048,796 

Priority date: 4-29-2008

Foreign filing: tbd

Burnham ID: 08-024



Available for license

Innovation Details

File Number: 08-024/REED* 

IP Protection

License Online

This innovation currently is not available for online licensing. Please contact Glenn Dourado, M. Sc., MBA at Sanford-Burnham Medical Research Institute for more information.

Request more info via email request more info

Case Manager:

Glenn Dourado, M. Sc., MBA Glenn Dourado, M. Sc., MBA

Innovations (166)

Download Technology Brief (PDF)

Followed By

Follow this innovation

No one is following this innovation.

Related Tags

Find more innovations

February 11, 2009

13,712 members 17,881 innovations 176 organizations


Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...